View in EDS HTML Full Text PDF Full Text

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.

Saved in:
Bibliographic Details
Title: Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.
Authors: Papp KA; Probity Medical Research and Alliance Clinical Trials, 135 Union St E, Waterloo, ON, N2J 1C4, Canada. kapapp@probitymedical.com.; Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. kapapp@probitymedical.com., Del Rosso JQ; JDR Dermatology Research, Las Vegas, NV, USA., Lebwohl MG; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Gooderham MJ; SKiN Centre for Dermatology, Peterborough, ON, Canada.; Probity Medical Research, Peterborough, ON, Canada.; Queen's University, Peterborough, ON, Canada., Hebert AA; UTHealth McGovern Medical School, Houston, TX, USA., Hong HC; Department of Dermatology and Skin Science, University of British Columbia, Surrey, BC, Canada.; Probity Medical Research, Surrey, BC, Canada., Kircik LH; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Indiana Medical Center, Indianapolis, IN, USA.; Physicians Skin Care, PLLC, Louisville, KY, USA.; Skin Sciences, PLLC, Louisville, KY, USA., Pariser DM; Eastern Virginia Medical School, Norfolk, VA, USA., Stein Gold L; Henry Ford Medical Center, Detroit, MI, USA., Strober B; Yale School of Medicine, New Haven, CT, USA., Seal MS; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Krupa D; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Chu DH; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Burnett P; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Berk DR; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Higham RC; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2025 Dec; Vol. 15 (12), pp. 3733-3744. Date of Electronic Publication: 2025 Oct 24.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41134450
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Papp+KA%22">Papp KA</searchLink>; Probity Medical Research and Alliance Clinical Trials, 135 Union St E, Waterloo, ON, N2J 1C4, Canada. kapapp@probitymedical.com.; Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. kapapp@probitymedical.com.<br /><searchLink fieldCode="AU" term="%22Del+Rosso+JQ%22">Del Rosso JQ</searchLink>; JDR Dermatology Research, Las Vegas, NV, USA.<br /><searchLink fieldCode="AU" term="%22Lebwohl+MG%22">Lebwohl MG</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gooderham+MJ%22">Gooderham MJ</searchLink>; SKiN Centre for Dermatology, Peterborough, ON, Canada.; Probity Medical Research, Peterborough, ON, Canada.; Queen's University, Peterborough, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Hebert+AA%22">Hebert AA</searchLink>; UTHealth McGovern Medical School, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hong+HC%22">Hong HC</searchLink>; Department of Dermatology and Skin Science, University of British Columbia, Surrey, BC, Canada.; Probity Medical Research, Surrey, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Kircik+LH%22">Kircik LH</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Indiana Medical Center, Indianapolis, IN, USA.; Physicians Skin Care, PLLC, Louisville, KY, USA.; Skin Sciences, PLLC, Louisville, KY, USA.<br /><searchLink fieldCode="AU" term="%22Pariser+DM%22">Pariser DM</searchLink>; Eastern Virginia Medical School, Norfolk, VA, USA.<br /><searchLink fieldCode="AU" term="%22Stein+Gold+L%22">Stein Gold L</searchLink>; Henry Ford Medical Center, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Strober+B%22">Strober B</searchLink>; Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Seal+MS%22">Seal MS</searchLink>; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.<br /><searchLink fieldCode="AU" term="%22Krupa+D%22">Krupa D</searchLink>; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chu+DH%22">Chu DH</searchLink>; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.<br /><searchLink fieldCode="AU" term="%22Burnett+P%22">Burnett P</searchLink>; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.<br /><searchLink fieldCode="AU" term="%22Berk+DR%22">Berk DR</searchLink>; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.<br /><searchLink fieldCode="AU" term="%22Higham+RC%22">Higham RC</searchLink>; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101590450%22">Dermatology and therapy</searchLink> [Dermatol Ther (Heidelb)] 2025 Dec; Vol. 15 (12), pp. 3733-3744. <i>Date of Electronic Publication: </i>2025 Oct 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare+Communications%22">Springer Healthcare Communications </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101590450 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8210 (Print) <i>NLM ISO Abbreviation: </i>Dermatol Ther (Heidelb) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41134450
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13555-025-01562-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3733
    Titles:
      – TitleFull: Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Papp KA
      – PersonEntity:
          Name:
            NameFull: Del Rosso JQ
      – PersonEntity:
          Name:
            NameFull: Lebwohl MG
      – PersonEntity:
          Name:
            NameFull: Gooderham MJ
      – PersonEntity:
          Name:
            NameFull: Hebert AA
      – PersonEntity:
          Name:
            NameFull: Hong HC
      – PersonEntity:
          Name:
            NameFull: Kircik LH
      – PersonEntity:
          Name:
            NameFull: Pariser DM
      – PersonEntity:
          Name:
            NameFull: Stein Gold L
      – PersonEntity:
          Name:
            NameFull: Strober B
      – PersonEntity:
          Name:
            NameFull: Seal MS
      – PersonEntity:
          Name:
            NameFull: Krupa D
      – PersonEntity:
          Name:
            NameFull: Chu DH
      – PersonEntity:
          Name:
            NameFull: Burnett P
      – PersonEntity:
          Name:
            NameFull: Berk DR
      – PersonEntity:
          Name:
            NameFull: Higham RC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2193-8210
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Dermatology and therapy
              Type: main
ResultId 1